Short Interest in Straumann Holding AG (OTCMKTS:SAUHY) Declines By 85.1%

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) saw a large decrease in short interest during the month of May. As of May 29th, there was short interest totaling 30,585 shares, a decrease of 85.1% from the May 14th total of 205,953 shares. Based on an average daily volume of 206,959 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

SAUHY has been the topic of several analyst reports. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Tuesday, April 14th. Citigroup reissued a “sell” rating on shares of Straumann in a report on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Reduce”.

Read Our Latest Research Report on Straumann

Straumann Stock Performance

OTCMKTS SAUHY opened at $11.85 on Friday. The company’s fifty day moving average is $11.13 and its two-hundred day moving average is $11.48. Straumann has a 52-week low of $9.44 and a 52-week high of $14.11.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Further Reading

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.